TriSalus Life Sciences Ownership & Insider Activity

TriSalus Life Sciences (TLSI) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 9.7% of shares outstanding. Institutional investors hold 15.6%. Over the past 90 days, insiders made 3 sales worth $4K.

Shares Outstanding

61.575M

Shares Float

46.662M

Insider Shares Owned

5.946M

Insider % Owned

9.7%

Institutional Shares Held

9.612M

Institutional % Held

15.6%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$4K total

Net Activity

Net Selling

Net Value (90d)

-$4K

TriSalus Life Sciences Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 5, 2026	Bryan Cox	CHIEF RESEARCH	SELL	296.000	$4.39	$1K
Oct 5, 2026	Richard Marshak	CHIEF COMMERCIAL OFFICER	SELL	325.000	$4.39	$1K
Oct 5, 2026	Jennifer Stevens	CHIEF REGULATORY OFFICER	SELL	316.000	$4.39	$1K
May 15, 2026	Richard Marshak	CHIEF COMMERCIAL OFFICER	SELL	543.000	$2.67	$1K
May 15, 2026	Mats Wahlstrom	DIRECTOR	BUY	60.000K	$2.53	$152K
May 15, 2026	Michael Stansky	DIRECTOR	BUY	610.000K	$2.50	$1.5M
May 15, 2026	Mary Szela	CEO AND PRESIDENT	BUY	39.682K	$2.59	$103K
May 15, 2026	David Patience	CHIEF FINANCIAL OFFICER	BUY	7.100K	$2.43	$17K
May 15, 2026	Gary Gordon	DIRECTOR	BUY	10.000K	$2.46	$25K